Tag: Regeneron
Dupixent approved in India for treating atopic dermatitis
Sanofi healthcare India has received marketing authorization for Dupixent (dupilumab), the first biologic medicine for the treatment of moderate-to-severe atopic dermatitis in adults whose...
